Coronary Insufficiency
Cohort Study: B‐Type Natriuretic Peptide and long‐term cardiovascular mortality in patients with coronary heart disease.
1 Jul, 2022 | 11:04h | UTC
RCT: Prothrombin complex concentrate vs. plasma for post–cardiopulmonary bypass coagulopathy and bleeding.
30 Jun, 2022 | 10:50h | UTCProthrombin Complex Concentrate vs Plasma for Post–Cardiopulmonary Bypass Coagulopathy and Bleeding: A Randomized Clinical Trial – JAMA Surgery (free for a limited period)
Commentary on Twitter
In this RCT of cardiac surgical patients, there was no significant difference in postoperative bleeding among patients receiving prothrombin complex concentrates (PCCs) or plasma. Fewer patients with PCCs required intraoperative RBCs after treatment. https://t.co/vqtNX7hQxA
— JAMA Surgery (@JAMASurgery) June 29, 2022
RCT: Effectiveness and safety of early initiation of poststernotomy cardiac rehabilitation exercise training.
23 Jun, 2022 | 12:59h | UTCEffectiveness and Safety of Early Initiation of Poststernotomy Cardiac Rehabilitation Exercise Training: The SCAR Randomized Clinical Trial – JAMA Cardiology (free for a limited period)
Commentary on Twitter
RCT found starting exercise 2 weeks post-sternotomy was as effective as starting at 6 weeks. Clinicians and cardiac rehabilitation professionals can recommend starting exercise training as early as 2 weeks post-sternotomy. https://t.co/MpBhRmyfUh
— JAMA Cardiology (@JAMACardio) June 22, 2022
M-A: Early versus delayed complete revascularization in patients presenting with ST-segment elevation myocardial infarction and multivessel disease.
23 Jun, 2022 | 10:11h | UTC
Cohort Study: Association between short-term, chronic localized and chronic widespread pain and risk for cardiovascular disease.
22 Jun, 2022 | 11:18h | UTC
Safety of bariatric surgery in patients with previous acute coronary events or heart failure: nationwide cohort study.
21 Jun, 2022 | 10:44h | UTC
Commentary on Twitter
#Bariatric surgery improves metabolic health of patients, but what are the risks if they have had MI before surgery?
National dataset matched 16000 pts??
Heart dis assoc w/? cardiac events post op, plus ?risk of SBO and stricture.#SoMe4Surgery https://t.co/iHsZiHIgdG pic.twitter.com/v2SXMpcZd3— BJS Open (@BjsOpen) June 17, 2022
M-A: Comparison of bifurcation techniques for percutaneous coronary intervention.
21 Jun, 2022 | 10:50h | UTC
Prospective head-to-head comparative study: Functional stress imaging to predict abnormal coronary fractional flow reserve.
20 Jun, 2022 | 01:10h | UTC
Commentary on Twitter
Functional stress imaging to predict abnormal coronary fractional flow reserve: new insights from the PACIFIC 2 study!https://t.co/5N0dOW2Rem#PET #MRI #FFR #CCS #coronary #cardiotwitter @escardio @ESC_Journals pic.twitter.com/WCoA0cOgd9
— EHJ Editor-in-Chief (@ehj_ed) June 17, 2022
Under a https://creativecommons.org/licenses/by-nc/4.0/ license
Post Hoc Secondary Analysis of RCT: Rivaroxaban monotherapy is associated with better outcomes vs. combination therapy with antiplatelets in patients with atrial fibrillation and stable coronary artery disease.
17 Jun, 2022 | 11:07h | UTCRivaroxaban Monotherapy vs Combination Therapy With Antiplatelets on Total Thrombotic and Bleeding Events in Atrial Fibrillation With Stable Coronary Artery Disease: A Post Hoc Secondary Analysis of the AFIRE Trial – JAMA Cardiology (free for a limited period)
Commentaries:
Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Disease: Does Less Mean More? – JAMA Cardiology (free for a limited period)
Rivaroxaban Monotherapy Linked to Lower Event Risk in Patients with AF, Stable CAD – HCPLive
Commentary on Twitter
In this post-hoc study of the AFIRE RCT, recurrent event analyses showed that rivaroxaban monotherapy was associated with lower risks of total thrombotic and/or bleeding events than rivaroxaban plus antiplatelet therapy in patients with AF and stable CAD. https://t.co/TGwatvlrKR
— JAMA Cardiology (@JAMACardio) June 15, 2022